Found 18 matching trials
Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia
PHASE1This is a Phase 1 clinical study designed to evaluate the safety, tolerabil...
Location
Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital
Off-the-shelf CD123 CAR-NK for R/R AML
EARLY_PHASE1This is a single-centre, single-arm, open-label, first-in-human (FIH) study...
Location
Peking University People's Hospital
Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL
PHASE3The aim of this study is to answer the following independent questions in t...
Location
General University Hospital, 1St Department of Medicine
CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma
PHASE2First-line CAR-T-cell consolidation after an abbreviated induction with 2 c...
Location
University Hospital of Mainz
A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients
PHASE3The purpose of this study is to determine whether R-FC is more beneficial t...
Location
Aberdeen Royal Infirmary
CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas
PHASE1This is a multi-center, open-label, non-randomized, single-arm clinical tri...
Location
Beijing GoBroad Hospital
A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma
PHASE1This open-label, randomized, phase Ib study will assess the safety and effi...
Location
Multiple Locations
CAR-NK Targeted CD19 for r/r B-cell Malignancies
PHASE1This is a single-centre, single-arm and open-label study to investigate the...
Location
The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital
Anti-BCMA CAR T-Cell Therapy for R/R ITP
PHASE2This is a prospective, single-center, open-label, single-arm study, to eval...
Location
The First Affiliated Hospital of Soochow University
Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL
PHASE1The team has developed the synthetic T cell receptor (TCR) and antigen rece...
Location
Biotherapeutic Department of Chinese PLA General Hospital